SCHEMBL2314342

SCHEMBL2314342

CCc1ccc2c(c1)C(C=CC(C)=O)=CC(C)(C)CO2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.37
MAOA P21397 1/20 0.37
TRPV1 Q8NER1 1/20 0.35
KMT2A Q03164 4/20 0.32
MEN1 O00255 3/20 0.32
ACACB O00763 1/20 0.31
PTGS1 P23219 2/20 0.31
PTGS2 P35354 2/20 0.31
MAPT P10636 2/20 0.31
RAB9A P51151 2/20 0.31
ALDH1A1 P00352 2/20 0.30
KDM4E B2RXH2 1/20 0.30
GAA P10253 1/20 0.30
HPGD P15428 1/20 0.30
CYP3A4 P08684 1/20 0.30
NPC1 O15118 1/20 0.30
LMNA P02545 1/20 0.30
ALOX12 P18054 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2314330 1.00 PARP1 (0.37) PARP1MAOATRPV1KMT2AMEN1
SCHEMBL3603083 0.88 RXRA (0.41) PARP1MAOATRPV1KMT2AMEN1
SCHEMBL2314576 0.88 RXRA (0.41) PARP1MAOATRPV1KMT2AMEN1
SCHEMBL3597753 0.85 KDM4E (0.37) PARP1MAOATRPV1KMT2AMEN1
SCHEMBL3597750 0.85 KDM4E (0.37) PARP1MAOATRPV1KMT2AMEN1
SCHEMBL2315354 0.84 MAPT (0.35) TRPV1KMT2AMEN1MAPTRAB9A
SCHEMBL2315349 0.84 MAPT (0.35) TRPV1KMT2AMEN1MAPTRAB9A
SCHEMBL2316995 0.83 ALDH1A1 (0.39) MAOATRPV1MAPTALDH1A1KDM4E
SCHEMBL2316992 0.83 ALDH1A1 (0.39) MAOATRPV1MAPTALDH1A1KDM4E
SCHEMBL2315966 0.83 AR (0.35) MAOATRPV1KMT2AMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1609786-B1 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids MERCK SANTE SAS (FR) 2011-08-03 EP claimed
EP-1758876-A1 NEW 5-ALKENONE-3,3-DIMETHYL-BENZOXEPINES DERIVATIVES USEFUL FOR THE PREPARATION OF ANTIDIABETIC PENTADIENOIC ACIDS MERCK PATENT GmbH (DE) 2007-03-07 EP claimed
WO-2006002721-A1 NEW 5-ALKENONE-3,3-DIMETHYL-BENZOXEPINES DERIVATIVES USEFUL FOR THE PREPARATION OF ANTIDIABETIC PENTADIENOIC ACIDS MERCK PATENT GMBH (DE) 2006-01-12 WO claimed
EP-1609786-A1 New 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids Merck Sante (FR) 2005-12-28 EP claimed
EP-1609786-B1 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids MERCK SANTE SAS (FR) 2011-08-03 EP disclosed
EP-1758876-A1 NEW 5-ALKENONE-3,3-DIMETHYL-BENZOXEPINES DERIVATIVES USEFUL FOR THE PREPARATION OF ANTIDIABETIC PENTADIENOIC ACIDS MERCK PATENT GmbH (DE) 2007-03-07 EP disclosed
WO-2006002721-A1 NEW 5-ALKENONE-3,3-DIMETHYL-BENZOXEPINES DERIVATIVES USEFUL FOR THE PREPARATION OF ANTIDIABETIC PENTADIENOIC ACIDS MERCK PATENT GMBH (DE) 2006-01-12 WO disclosed
EP-1609786-A1 New 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids Merck Sante (FR) 2005-12-28 EP disclosed